Arrowhead Research | ARWR - Nettoeinkommen





Nettoeinkommen Veränderung Datum
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Alnylam Pharmaceuticals USD 205.99M 19.57M 2026-03
Anika Therapeutics USD 292K 2.62M 2025-12
Arrowhead Research USD -132.73M 163.54M 2026-03
Heron Therapeutics USD -2.95M 14.54M 2025-12
Incyte USD 303.33M 4.05M 2026-03
Ionis Pharmaceuticals USD -93M 136M 2026-03
Ligand Pharmaceuticals USD -13.34M 58.13M 2026-03
Merck USD -4.24B 7.2B 2026-03
Moderna USD -1.34B 517M 2026-03
Nektar Therapeutics USD -36.08M 978K 2025-12
Novartis USD 3.16B 747M 2026-03
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
TG Therapeutics USD 19.78M 3.26M 2026-03
Ultragenyx Pharmaceutical USD -185M 56M 2026-03
Vertex Pharmaceuticals USD 1.03B 159.7M 2026-03
Xencor USD -128.92M 122.26M 2026-03